PT  - JOURNAL ARTICLE
AU  - Rudin, Charles M
AU  - Pandha, Hardev S
AU  - Zibelman, Matthew
AU  - Akerley, Wallace L
AU  - Harrington, Kevin J
AU  - Day, Daphne
AU  - Hill, Andrew G
AU  - O'Day, Steven J
AU  - Clay, Timothy D
AU  - Wright, Gavin M
AU  - Jennens, Ross R
AU  - Gerber, David E
AU  - Rosenberg, Jonathan E
AU  - Ralph, Christy
AU  - Campbell, David C
AU  - Curti, Brendan D
AU  - Merchan, Jaime R
AU  - Ren, Yixin
AU  - Schmidt, Emmett V
AU  - Guttman, Lisa
AU  - Gupta, Sumati
TI  - Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
AID  - 10.1136/jitc-2022-005007
DP  - 2023 Jan 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e005007
VI  - 11
IP  - 1
4099  - http://jitc.bmj.com/content/11/1/e005007.short
4100  - http://jitc.bmj.com/content/11/1/e005007.full
SO  - J Immunother Cancer2023 Jan 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.